Skip to main navigation Skip to search Skip to main content

Disección farmacogenómica de un caso de rabdomiólisis inducida por rosuvastatina

Translated title of the contribution: Pharmacogenomic dissection of a case of rosuvastatin-induced rhabdomyolysis

Research output: Knowledge networks › Poster › peer-review

Abstract

Pharmacogenetics explains the implication of DNA variation in the occurrence of adverse drug reactions. The identification of people with genetic susceptibility to develop undesirable events is of great impact for the patient's quality of life and for the country's economy. In this work we performed an extended genomic analysis by next generation sequencing that allowed us to establish a genomic risk profile in a patient who developed rhabdomyolysis secondary to rosuvastatin.
Translated title of the contributionPharmacogenomic dissection of a case of rosuvastatin-induced rhabdomyolysis
Original languageSpanish (Colombia)
Pages1-1
Number of pages1
StateSubmitted - Nov 1 2019
EventIV Encuentro de Investigación CIMED - Bogota, Colombia
Duration: Nov 1 2019 → …

Other

OtherIV Encuentro de Investigación CIMED
Country/TerritoryColombia
CityBogota
Period11/1/19 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Genetics

Fingerprint

Dive into the research topics of 'Pharmacogenomic dissection of a case of rosuvastatin-induced rhabdomyolysis'. Together they form a unique fingerprint.

Cite this